Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
FAQs
Advertising
Report Store
UsernamePublicRestriction
Tags:
OTC Drugs

Eye On The Pie: Perrigo Growth Depends On Fingers In New Categories

This article was originally published in The Tan Sheet

  • News
  • The Tan Sheet

Executive Summary

Perrigo's growth strategy will continue to depend on launches in new product categories, largely through acquisitions

You may also be interested in...



Perrigo Plots Nutritionals Turnaround Following Record Year

Turning around a nutritionals business saddled with high costs remains a top priority for Perrigo as it reports record overall sales in its fiscal 2009

Leiner Auction Outcome Will Shift Balance Of Power For Supplement Players

The auction of Leiner Health Products slated for June 9 will reshape the competitive landscape for the dietary supplement market whether the winner is Perrigo or NBTY

People In Brief

Perrigo promotes in pricing, planning

Table

View full table

Topics

Tags:
OTC Drugs
UsernamePublicRestriction

Register

LL1133833

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By